Public
Health care leaders: Drug shortages a ‘major threat’ to patients
A dozen health care leaders testified before the Joint Committee on Public Health today about the effects of the growing problem of drug shortages linked to manufacturing problems and the rise of the “grey market,” in which drug suppliers stockpile medications then sell them at inflated prices. The shortages are particularly severe among drugs that are injected intravenously, including one to ………click here to continue reading